12/05/2021

EuropaBio celebrated its inaugural National Associations Council Summit: Collaborations and trust are vital to build a responsive and competetive biotech sector in Europe

IP waiver for COVID-19 vaccines is a misguided and ineffective response to a shared global challenge. In the long run, the waiver proposal undermines the existing vaccine eco-system built in the crisis urgency.
06/05/2021

EU Industrial Strategy 2020: EuropaBio welcomes increased focus on competitiveness and resilience, driven by innovation and advanced technologies

EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet.
27/04/2021

EuropaBio proposes how to increase competitiveness of biotechnology sector in the EU

EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet.